Gastric Cancer Information Center
Each year in the United States, more than 21,000 people are diagnosed with gastric cancer (stomach cancer). Thanks to improvements in treatment, however, gastric cancer patients are living longer. It is estimated that there are more than 63,000 gastric cancer survivors in the U.S. today.
Advances in surgery, chemotherapy, and radiation therapy have all contributed to improved gastric cancer survival. In addition, advances in supportive care have made gastric cancer treatment more tolerable, leading to improved quality of life.
Understanding gastric cancer treatment options, the role of different doctors specializing in the treatment of gastric cancer, and how and when to access new and innovative gastric cancer treatment options available through clinical trials is essential in order to achieve the best outcome from gastric cancer treatment.
The Cancer Consultants Gastric Cancer Information Center has been designed to help patients understand gastric cancer and gastric cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of gastric cancer.
Headline Gastric Cancer News 
Herceptin Improves Outcome of HER2-positive Stomach Cancer
Addition of Herceptin to chemotherapy improves survival.
Aspirin May Reduce Risk of Stomach Cancer
Regular aspirin use may reduce the risk of distal stomach cancer.
Gastric Cancer Tips
What to Tell Children when Facing a Diagnosis of Cancer If you have children in your life, you already know that they tend to be creatures...
Chemotherapy for Older Patients with Cancer: What You Should Know About the Risk of a Low White Blood Cell Count As you may already know, chemotherapy works by attacking the rapidly dividing cells...
Gastric Cancer Patients: Understanding Peripheral Neuropathy If you’ve received chemotherapy as part of your gastric cancer treatment, one of...
Gastric Cancer Management
Inspiration, Hope & Resources
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Pay it Forward Survivors become peer mentors to newly diagnosed women and offer experience, insight,...
Gastric Cancer Conference Coverage
Advances in Non-colorectal Gastrointestinal Malignancies This year’s ASCO saw a number of significant trials that were either practice-changing or had major effects on the field of treatment of non-colorectal gastrointestinal cancers.
Gastric Cancer Clinical Trials
USOR06054 – A Randomized Phase II Study of Docetaxel in Combination with Oxaliplatin with or without 5-FU or Capecitabine in Metastatic or Locally Recurrent Gastric Cancer previously untreated with Chemotherapy for Advanced Disease (GATE Study)
Z9001 – A Phase III Randomized Double-blind Study of Adjuvant STI571 (Gleevec) Versus Placebo in Patients Following The Resection of Primary GastroIntestinal Stromal Tumor (GIST)
REFMAL39 – A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
 |
 |
 |
 |
